Press release
Rituximab Biosimilars Market Is Booming Worldwide (2020-2023) | By Top Leading Players – Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd.
The Business Research Company
The global rituximab biosimilars market is expected to decline from $1.84 billion in 2019 to $1.78 billion in 2020 at a compound annual growth rate (CAGR) of -3.22%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $2.62 billion in 2023 at a CAGR of 13.85%.
Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3430
The rituximab biosimilars market consists of sales of rituximab biosimilars. Biosimilars are pharmaceuticals that are manufactured using cell lines and are similar to biologics. Rituximab biosimilars are used as a single agent or in combination with chemotherapy for the treatment of various diseases including chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), microscopic polyangiitis (MPA), and granulomatosis with polyangiitis (GPA).
The companies operating in the biosimilars market are continuously focusing on new product development in collaborations with other companies in the industry. Innovation through partnerships is shaping the rituximab biosimilars market.
Rituximab Biosimilars Market Segmentation:
By Application
1. Non-Hodgkin’s lymphoma,
2. Chronic Lymphocytic Leukemia,
3. Rheumatoid arthritis, Others
Hospital Pharmacy
1. Hospital Pharmacy,
2. Online Pharmacy,
3. Retail Pharmacy,
4. Other Direct Distribution Channels.
Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/rituximab-biosimilars-global-market-report-2020-30-covid-19-growth-and-change
Few Points From Table Of Content
1. Executive Summary
2. Rituximab Biosimilars Market Characteristics
3. Rituximab Biosimilars Market Size And Growth
4. Rituximab Biosimilars Market Segmentation
5. Rituximab Biosimilars Market Regional And Country Analysis
……
25. Rituximab Biosimilars Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Rituximab Biosimilars Market
27. Rituximab Biosimilars Market Trends And Strategies
28. Rituximab Biosimilars Market Future Outlook and Potential Analysis
29. Appendix
The report covers the trends and market dynamics of the rituximab biosimilars market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3430&type=smp
Some of the key players involved in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. Ltd., Sandoz International GmbH, Reliance Life Sciences, C.H. Boehringer Sohn AG & Ko. KG, BioXpress Therapeutics SA, Intas Biopharmaceuticals Ltd
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rituximab Biosimilars Market Is Booming Worldwide (2020-2023) | By Top Leading Players – Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd. here
News-ID: 2144042 • Views: …
More Releases from The Business research company
Well Testing Services Market to Reach$10.54 Billion by 2028, Fueled by Global Oi …
The well testing services market size has grown strongly in recent years. It will grow from $7.78 billion in 2023 to $8.27 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to global energy demand, exploration and production activities, reservoir management, asset integrity management, multi-well testing campaigns, rise in deepwater and ultra-deepwater exploration.
The well testing services market size…
Strong Growth Expected in Well Intervention Market, Reaching $12.06 Billion by 2 …
The well intervention market size has grown strongly in recent years. It will grow from $8.93 billion in 2023 to $9.47 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to reservoir management and optimization, economic viability, production enhancement, regulatory compliance, emergency response and well control, maturing oil and gas fields.
The well intervention market size is expected to…
Well Completion Equipment Market to Reach $14.19 Billion by 2028, Fueled by Oil …
The well completion equipment and services market size has grown strongly in recent years. It will grow from $9.93 billion in 2023 to $10.67 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to oil demand, hydraulic fracturing revolution, deepwater exploration, market volatility, geopolitical factors.
The well completion equipment and services market size is expected to see strong growth…
Well Cementing Services Market to Reach $14.92 Billion by 2028, Fueled by Indust …
The well cementing services market size has grown strongly in recent years. It will grow from $10.32 billion in 2023 to $11.13 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to industry consolidation and market dynamics, standardization and quality control, safety and risk mitigation, geopolitical and economic facto, training and skilled workforce development.
The well cementing services market…
More Releases for Rituximab
Rituxan (rituximab) Drug Market Trends, Demand Service, Share, Industry Size, Gr …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Rituxan (rituximab) Drug market with holistic insights into vital factors and aspects that impact future market growth. The global Rituxan (rituximab) Drug market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Rituxan (rituximab) Drug market and its critical dynamics, the research study…
2022 Rituximab Biosimilars Market Report, Overview, Size, Trends, Growth And For …
'Rituximab Biosimilars Global Market Report 2022 -Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The Rituximab Biosimilars market research report helps gain a truly global perspective of the Rituximab Biosimilars…
Global Rituximab Biosimilars Market 2021 : SWOT Analysis of Key Driving Factors …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now!
https://www.thebusinessresearchcompany.com/global-market-reports
‘Rituximab Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on.…
Complete Analysis On Rituximab Biosimilars Market | Global Key Trends Analysis, …
The Business Research Company offers "Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It…
Rituximab Biosimilars Market Share, Growth Insights, Regional Overview, Competit …
The rituximab biosimilar market reached a value of nearly $1,602.1 million in 2020, having increased at a compound annual growth rate (CAGR) of 67.9% since 2015. The market is expected to grow from $1,602.1 million in 2020 to $3,474.2 million in 2025 at a rate of 16.7%. The market is then expected to grow at a CAGR of 10.5% from 2025 and reach $5,723.6 million in 2030.
The Business…
Rituximab Drug Market Primary Research, Secondary Research, Product Research, Si …
QY Research has published a latest and most trending report on Rituximab Drug Market offers detailed value chain assessment, comprehensive study on market dynamics including drivers, restraints and opportunities, recent trends, and industry performance analysis. Furthermore, it digs deep into critical aspects of key subjects such as market competition, regional growth, and market segmentation so that readers could gain a sound understanding of the global Rituximab Drug market.
The global Rituximab…
